The contraceptive implant

Clinical Obstetrics and Gynecology

Volumn 50, Issue 4, 2007, Pages 907-917

  Hohmann, Heather ^a,c   Creinin, Mitchell D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Contraception; ENG implant; Implanon; Progestin only

Indexed keywords

COPPER INTRAUTERINE DEVICE; DOXYCYCLINE; ESTRADIOL; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; SEX HORMONE BINDING GLOBULIN;

ACNE; ARTICLE; BLEEDING; BODY MASS; BONE DENSITY; CONTRACEPTION; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; ESTRADIOL BLOOD LEVEL; HUMAN; IMPLANT; LACTATION; LIPID BLOOD LEVEL; LIVER FUNCTION; OVARY CYST; OVARY FOLLICLE CELL; OVULATION; SIDE EFFECT; UNITED STATES; VAGINA BLEEDING;

ACNE VULGARIS; BONE DENSITY; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DEVICE REMOVAL; DRUG IMPLANTS; FEMALE; HUMANS; LIPID METABOLISM; LIVER; MENSTRUATION DISTURBANCES; OVARIAN CYSTS; PATIENT SATISFACTION; SAFETY; TIME FACTORS;

EID: 35848952267     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e318159c2f6     Document Type: Article

References (48)

1. Meckstroth KR, Darney PD. Implant contraception. Semin Reprod Med. 2001;19:339-354.
2. Meirik O, Farley TM, Sivin I. Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization. Obstet Gynecol. 2001;97:539-547.
3. Sivin I, Mishell DR Jr, Diaz S, et al. Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study. Contraception. 2000;61:187-194.
4. Sivin I. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants. Drug Saf. 2003;26:303-335.
5. Haukkamaa M, Laurikka-Routti M, Heikinheimo O, et al. Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study. Contraception. 1992;45:49-55.
6. Sivin I, Croxatto H, Bahamondes L, et al. Two-year performance of a Nestorone(R)-releasing contraceptive implant: a three-center study of 300 women. Contraception. 2004;69:137-144.
7. Coutinho EM, de Souza JC, Athayde C, et al. Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant. Contraception. 1996;53:121-125.
8. Barbosa IC, Maia H Jr, Coutinho E, et al. Effects of a single Silastic contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year. Contraception. 2006;74:492-497.
9. Boonstra H, Duran V, Northington Gamble V, et al. The "boom and bust phenomenon": the hopes, dreams, and broken promises of the contraceptive revolution. Contraception. 2000;61:9-25.
10. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device). Contraception. 2000;62:239-246.
11. Taneepanichskul S, Reinprayoon D, Thaithumyanon P, et al. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception. 2006;73:368-371.
12. Croxatto HB. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care. 2000;5(suppl 2):21-28.
13. Edwards JE, Moore A. Implanon. A review of clinical studies. Br J Fam Plann. 1999;24(4 suppl):3-16.
14. Croxatto HB. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception. 2002;65:21-27.
15. Implanon (package insert). 2006, Organon USA Inc: Roseland, NJ.
16. [cited; 8/15/07]. Available from: http://www.implanon-usa.com/media/ imagebank/index.asp?C=54991393098966782407&svarqvp2=0.
17. Wenzl R, van Beek A, Schnabel P, et al. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. Contraception. 1998;58:283-288.
18. Makarainen L, van Beek A, Tuomivaara L, et al. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril. 1998;69:714-721.
19. Diaz S, Pavez M, Moo-Young AJ, et al. Clinical trial with 3-keto-desogestrel subdermal implants. Contraception. 1991;44:393-408.
20. IMPLANON approval letter, U.F.a.D. Administration, Editor. 2006, US Food and Drug Administration.
21. Croxatto HB, Makarainen L. The pharmacodynamics and efficacy of Implanon. An overview of the data. Contraception. 1998;58(6 suppl):91S-97S.
22. Davies GC, Feng LX, Newton JR, et al. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel. Contraception. 1993;47:251-261.
23. Funk S, Miller MM, Mishell DR Jr, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005;71:319-326.
24. Croxatto HB, Urbancsek J, Massai R, et al. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod. 1999;14:976-981.
25. Flores JB, Balderas ML, Bonilla MC, et al. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant. Int J Gynaecol Obstet. 2005;90:228-233.
26. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception. 2005;71:306-308.
27. Zheng SR, Zheng HM, Qian SZ, et al. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant. Contraception. 1999;60:1-8.
28. Bitzer J, Tschudin S, Alder J. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Health Care. 2004;9:278-284.
29. Witjaksono J, Lau TM, Affandi B, et al. Oestrogen treatment for increased bleeding in Norplant users: preliminary results. Hum Reprod. 1996;11(suppl 2):109-114.
30. Weisberg E, Hickey M, Palmer D, et al. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod. 2006;21:295-302.
31. Alvarez-Sanchez F, Brache V, Thevenin F, et al. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol. 1996;174:919-922.
32. Cheng L, Zhu H, Wang A, et al. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod. 2000;15:1969-1972.
33. Beerthuizen R, van Beek A, Massai R, et al. Bone mineral density during long-term use of the progestogen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod. 2000;15:118-122.
34. Bahamondes L, Monteiro-Dantas C, Espejo-Arce X, et al. A prospective study of the forearm bone density of users of etonogestreland levonorgestrel-releasing contraceptive implants. Hum Reprod. 2006;21:466-470.
35. Lakha F, Glasier AF. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception. 2006;74:287-289.
36. Croxatto HB. Progestin implants. Steroids. 2000;65:681-685.
37. Hidalgo MM, Lisondo C, Juliato CT, et al. Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants. Contraception. 2006;73:532-536.
38. Biswas A, Viegas OA, Roy AC. Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids - a randomized comparative study. Contraception. 2003;68:189-193.
39. Biswas A, Biswas S, Viegas OA. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests - a randomized comparative study with Norplant implants. Contraception. 2004;70:379-382.
40. Egberg N, van Beek A, Gunnervik C, et al. Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial. Contraception. 1998;58:93-98.
41. Farrington A. Today's contraceptive options: finding the right fit. Health Sexuality. 2001;6:4-6.
42. Hatcher R, Trussell J, Stewart F, et al. Contraceptive Technology. 18th Revised ed. New York: Ardent Media, Inc.; 2004.
43. Westhoff C, Kerns J, Morroni C, et al. Quick start: novel oral contraceptive initiation method. Contraception. 2002;66:141-145.
44. Shulman LP, Gabriel H. Management and localization strategies for the nonpalpable Implanon rod. Contraception. 2006;73:325-330.
45. Cullins VE, Blumenthal PD, Remsburg RE, et al. Preliminary experience with Norplant in an inner city population. Contraception. 1993;47:193-203.
46. Pymar HC, Creinin MD, Schwartz JL. "Popout" method of levonorgestrel implant removal. Contraception. 1999;59:383-387.
47. Lantz A, Nosher JL, Pasquale S, et al. Ultrasound characteristics of subdermally implanted Implanon contraceptive rods. Contraception. 1997;56:323-327.
48. Westerway SC, Picker R, Christie J. Implanon implant detection with ultrasound and magnetic resonance imaging. Aust N Z J Obstet Gynaecol. 2003;43:346-350.